ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$16.86 USD
-0.01 (-0.06%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $16.88 +0.02 (0.12%) 5:06 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.87 |
EPS Last Quarter | -0.93 |
Last EPS Surprise | -10.71% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.33 |
Next Year | -2.85 |
EPS (TTM) | -3.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.87 | -0.87 | -3.33 | -2.85 |
# of Estimates | 4 | 4 | 5 | 3 |
Most Recent Consensus | -0.78 | -0.72 | -2.80 | -2.16 |
High Estimate | -0.74 | -0.72 | -2.80 | -2.16 |
Low Estimate | -0.99 | -1.00 | -4.00 | -3.62 |
Year ago EPS | -0.58 | -0.84 | -3.74 | -3.33 |
Year over Year Growth Est. | -50.00% | -3.57% | 10.96% | 14.20% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.87 | -0.87 | -3.33 | -2.85 |
7 Days Ago | -0.87 | -0.87 | -3.33 | -2.85 |
30 Days Ago | -0.87 | -0.87 | -3.33 | -2.85 |
60 Days Ago | -0.85 | -0.86 | -3.41 | -3.09 |
90 Days Ago | -0.85 | -0.86 | -3.41 | -3.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.87 | -0.87 | -3.33 | -2.85 |
Zacks Consensus Estimate | -0.87 | -0.87 | -3.33 | -2.85 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.93 | -1.24 | -0.84 | -0.58 | NA |
Estimate | -0.84 | -0.86 | -0.85 | -0.84 | NA |
Difference | -0.09 | -0.38 | 0.01 | 0.26 | -0.05 |
Surprise | -10.71% | -44.19% | 1.18% | 30.95% | -5.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more